IPOs & Offerings

Laser Photonics files Form S-1 for resale of warrant-linked common shares

The preliminary registration statement covers common shares that may be resold by selling stockholders after the registration statement becomes effective.

By Carter Hayes ยท

Key takeaways

  • Laser Photonics filed a preliminary Form S-1 registration statement with the SEC on July 30, 2026, for the resale of common shares issuable upon exercise of warrants.
  • The filing states that the company will not receive proceeds from sales of the registered shares by selling stockholders, although it could receive cash if warrants are exercised,
  • The warrants have an exercise price of $0.975 per share. Series A-7 warrants expire five years after the registration statement becomes effective, and Series A-8 warrants expire 24
  • The selling stockholders may sell any, all or none of the shares after effectiveness through public or private transactions. The company does not know when or in what amount sales

Preliminary resale registration statement

Laser Photonics Corporation filed a Form S-1 registration statement on July 30, 2026. The document is a preliminary prospectus subject to completion and states that the securities may not be sold until the registration statement is effective.

The prospectus concerns shares issuable upon exercise of Series A-7 warrants, Series A-8 warrants and placement-agent warrants. The company is registering the shares on behalf of the selling stockholders, which may resell them from time to time after effectiveness.

Warrant exercise terms and proceeds

The warrants covered by the prospectus have an exercise price of $0.975 per share, subject to the adjustments described in the warrant terms. Series A-7 warrants expire five years after the registration statement becomes effective, while Series A-8 warrants expire 24 months after that effective date.

Laser Photonics states that it will not receive proceeds from sales of the shares by selling stockholders. It may receive cash equal to the aggregate exercise price if warrants are exercised for cash, but the filing says it cannot predict whether or when cash exercises will occur. If warrants expire unexercised or are exercised only on a cashless basis, the company would not receive cash proceeds from those exercises.

Potential sales after effectiveness

The selling stockholders and certain successors may sell shares in public or private transactions at prevailing market prices, prices related to prevailing market prices or negotiated prices. They may sell any, all or none of the shares.

The registration statement lists the proposed public sale date as as soon as practicable after its effective date. The prospectus says the company does not know when or in what amount the selling stockholders may sell shares following effectiveness.